Prolactinoma classification: Difference between revisions

	Prolactinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Prolactinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
ECG
X-ray
Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Prolactinoma classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Prolactinoma classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Prolactinoma classification
CDC on Prolactinoma classification
Prolactinoma classification in the news
Blogs on Prolactinoma classification
Directions to Hospitals Treating Prolactinoma
Risk calculators and risk factors for Prolactinoma classification

← Older edit

VisualWikitext

Latest revision as of 23:49, 29 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Anmol Pitliya, M.B.B.S. M.D.[3]

Overview

Prolactinoma can be classified based upon either size or local invasion. Based on size, a prolactinoma can be classified as a microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter).

Classification

Prolactinoma may be classified based on either size or local invasion.

Classification of prolactinoma
Classification basis		Type/Grade	Criteria
Classification based on size^[1]		Microprolactinoma	<10 mm diameter
Classification based on size^[1]		Macroprolactinoma	>10 mm diameter
Classificatioin based on local invasion^[2]^[3]^[4]	Size and Invasion	0	Normal pituitary appearance
		I	Enclosed within the sella turcica, microadenoma smaller than 10 mm
		II	Enclosed within the sella turcica, macroadenoma 10 mm or larger
		III	Invasive, locally, into the sella turcica
		IV	Invasive, diffusely, into the sella turcica
	Grading scheme for suprasellar extensions	A	0 to 10 mm suprasellar extension occupying the suprasellarcistern
		B	10 mm to 20 mm extension and elevation of the third ventricle
		C	20 mm to 30 mm extension occupying the anterior of the third ventricle
		D	A larger than 30 mm extension, beyond the foramen of Monro, or Grade C with lateral extensions

References

↑ Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004). "The prevalence of pituitary adenomas: a systematic review". Cancer. 101 (3): 613–9. doi:10.1002/cncr.20412. PMID 15274075.
↑ "Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute".
↑ Yeh PJ, Chen JW (1997). "Pituitary tumors: surgical and medical management". Surg Oncol. 6 (2): 67–92. PMID 09436654.
↑ Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98

Template:WikiDoc Sources

[pmid15274075-1] Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004). "The prevalence of pituitary adenomas: a systematic review". Cancer. 101 (3): 613–9. doi:10.1002/cncr.20412. PMID 15274075.

[urlPituitary_Tumors_Treatment_(PDQ®)—Health_Professional_Version_-_National_Cancer_Institute-2] "Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute".

[pmid09436654-3] Yeh PJ, Chen JW (1997). "Pituitary tumors: surgical and medical management". Surg Oncol. 6 (2): 67–92. PMID 09436654.

[4] Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98

[1]

[2]

[3]

[4]

@@ Line 8: / Line 8: @@
 Prolactinoma may be classified based on either size or local invasion.
-{|class="wikitable"
+{|
-! colspan="4" | Classification of prolactinoma
+! colspan="4" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF| Classification of prolactinoma}}
 |-
-! colspan="2" |Classification basis
+! colspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Classification basis}}
-!Type/Grade
+! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Type/Grade}}
-!Criteria
+! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Criteria}}
 |-
-| colspan="2" rowspan= "2" |Classification based on size<ref name="pmid15274075">{{cite journal |vauthors=Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE |title=The prevalence of pituitary adenomas: a systematic review |journal=Cancer |volume=101 |issue=3 |pages=613–9 |year=2004 |pmid=15274075 |doi=10.1002/cncr.20412 |url=http://onlinelibrary.wiley.com/doi/10.1002/cncr.20412/full}}</ref>
+| colspan="2" rowspan= "2" style="background: #DCDCDC; text-align: center;" |Classification based on size<ref name="pmid15274075">{{cite journal |vauthors=Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE |title=The prevalence of pituitary adenomas: a systematic review |journal=Cancer |volume=101 |issue=3 |pages=613–9 |year=2004 |pmid=15274075 |doi=10.1002/cncr.20412 |url=http://onlinelibrary.wiley.com/doi/10.1002/cncr.20412/full}}</ref>
-| Microprolactinoma
+| style="background: #F5F5F5; text-align: center;" |Microprolactinoma
-| <10 mm diameter
+| style="background: #F5F5F5;" | <10 mm diameter
 |-
-| Macroprolactinoma
+| style="background: #F5F5F5; text-align: center;" |Macroprolactinoma
-| >10 mm diameter
+| style="background: #F5F5F5;" | >10 mm diameter
 |-
-| rowspan="11" |Classificatioin based on local invasion<ref name="urlPituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute">{{cite web |url=https://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#cit/section_3.3 |title=Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute |format= |work= |accessdate=}}</ref><ref name="pmid09436654">{{cite journal| author=Yeh PJ, Chen JW| title=Pituitary tumors: surgical and medical management. | journal=Surg Oncol | year= 1997 | volume= 6 | issue= 2 | pages= 67-92 | pmid=09436654 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9436654  }}</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute,  January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref>
+| rowspan="11" style="background: #DCDCDC; text-align: center;" |Classificatioin based on local invasion<ref name="urlPituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute">{{cite web |url=https://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#cit/section_3.3 |title=Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute |format= |work= |accessdate=}}</ref><ref name="pmid09436654">{{cite journal| author=Yeh PJ, Chen JW| title=Pituitary tumors: surgical and medical management. | journal=Surg Oncol | year= 1997 | volume= 6 | issue= 2 | pages= 67-92 | pmid=09436654 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9436654  }}</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute,  January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref>
-| rowspan="5" |Size and Invasion
+| rowspan="5" style="background: #DCDCDC; text-align: center;" |Size and Invasion
-|0
+| style="background: #F5F5F5; text-align: center;" |0
-|Normal [[pituitary]] appearance
+| style="background: #F5F5F5;" |Normal [[pituitary]] appearance
 |-
-|I
+| style="background: #F5F5F5; text-align: center;" |I
-|Enclosed within the [[sella turcica]], microadenoma smaller than 10 mm
+| style="background: #F5F5F5;" |Enclosed within the [[sella turcica]], microadenoma smaller than 10 mm
 |-
-|II
+| style="background: #F5F5F5; text-align: center;" |II
-|Enclosed within the [[sella turcica]], macroadenoma 10 mm or larger
+| style="background: #F5F5F5;" |Enclosed within the [[sella turcica]], macroadenoma 10 mm or larger
 |-
-|III
+| style="background: #F5F5F5; text-align: center;" |III
-|Invasive, locally, into the [[sella turcica]]
+| style="background: #F5F5F5;" |Invasive, locally, into the [[sella turcica]]
 |-
-|IV
+| style="background: #F5F5F5; text-align: center;" |IV
-|Invasive, diffusely, into the [[sella turcica]]
+| style="background: #F5F5F5;" |Invasive, diffusely, into the [[sella turcica]]
 |-
-| rowspan="4" |Grading scheme for suprasellar extensions
+| rowspan="4" style="background: #DCDCDC; text-align: center;" |Grading scheme for suprasellar extensions
-|A
+| style="background: #F5F5F5; text-align: center;" |A
-|0 to 10 mm [[suprasellar]] extension occupying the [[suprasellar]]cistern
+| style="background: #F5F5F5;" |0 to 10 mm [[suprasellar]] extension occupying the [[suprasellar]]cistern
 |-
-|B
+| style="background: #F5F5F5; text-align: center;" |B
-|10 mm  to 20 mm extension and elevation of the [[third ventricle]]
+| style="background: #F5F5F5;" |10 mm  to 20 mm extension and elevation of the [[third ventricle]]
 |-
-|C
+| style="background: #F5F5F5; text-align: center;" |C
-|20 mm to 30 mm extension occupying the [[anterior]] of the [[third ventricle]]
+| style="background: #F5F5F5;" |20 mm to 30 mm extension occupying the [[anterior]] of the [[third ventricle]]
 |-
-|D
+| style="background: #F5F5F5; text-align: center;" |D
-|A larger than 30 mm extension, beyond the [[foramen of Monro]], or Grade C with lateral extensions
+| style="background: #F5F5F5;" |A larger than 30 mm extension, beyond the [[foramen of Monro]], or Grade C with lateral extensions
 |}
-===Classification based on size===
-Based on size, a prolactinoma can be classified as:<ref name="pmid15274075">{{cite journal |vauthors=Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE |title=The prevalence of pituitary adenomas: a systematic review |journal=Cancer |volume=101 |issue=3 |pages=613–9 |year=2004 |pmid=15274075 |doi=10.1002/cncr.20412 |url=http://onlinelibrary.wiley.com/doi/10.1002/cncr.20412/full}}</ref>
-*Microprolactinoma (<10 mm diameter)
-*Macroprolactinoma (>10 mm diameter)
-===Classificatioin based on local invasion===
-The classification for [[pituitary adenomas]] is as follows:<ref name="urlPituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute">{{cite web |url=https://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#cit/section_3.3 |title=Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute |format= |work= |accessdate=}}</ref><ref name="pmid09436654">{{cite journal| author=Yeh PJ, Chen JW| title=Pituitary tumors: surgical and medical management. | journal=Surg Oncol | year= 1997 | volume= 6 | issue= 2 | pages= 67-92 | pmid=09436654 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9436654  }}</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute,  January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref>
-*0: Normal [[pituitary]] appearance
-*I: Enclosed within the [[sella turcica]], microadenoma smaller than 10 mm
-*II: Enclosed within the [[sella turcica]], macroadenoma 10 mm or larger
-*III: Invasive, locally, into the [[sella turcica]]
-*IV: Invasive, diffusely, into the [[sella turcica]]
-The grading scheme for suprasellar extensions is as follows:
-*A: 0 to 10 mm [[suprasellar]] extension occupying the [[suprasellar]]cistern
-*B: 10 mm  to 20 mm extension and elevation of the [[third ventricle]]
-*C: 20 mm to 30 mm extension occupying the [[anterior]] of the [[third ventricle]]
-*D: A larger than 30 mm extension, beyond the [[foramen of Monro]], or Grade C with lateral extensions
 == References ==
@@ Line 76: / Line 57: @@
 {{WikiDoc Help Menu}}
 {{WikiDoc Sources}}
 [[Category:Disease]]
 [[Category:Neuroendocrinology]]
+[[Category:Oncology]]
+[[Category:Medicine]]
+[[Category:Endocrinology]]
+[[Category:Up-To-Date]]
+[[Category:Neurology]]
+[[Category:Neurosurgery]]

Prolactinoma classification: Difference between revisions

Latest revision as of 23:49, 29 July 2020

Overview

Classification

References

Navigation menu

Search